Takara Bio Inc
TSE:4974
Takara Bio Inc
Operating Income
Takara Bio Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Takara Bio Inc
TSE:4974
|
Operating Income
¥1.5B
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-2%
|
|
GNI Group Ltd
TSE:2160
|
Operating Income
¥5.2B
|
CAGR 3-Years
44%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
PeptiDream Inc
TSE:4587
|
Operating Income
¥6.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Pharma Foods International Co Ltd
TSE:2929
|
Operating Income
¥6B
|
CAGR 3-Years
39%
|
CAGR 5-Years
47%
|
CAGR 10-Years
48%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Operating Income
-¥155.3m
|
CAGR 3-Years
18%
|
CAGR 5-Years
17%
|
CAGR 10-Years
17%
|
S
|
StemRIM Inc
TSE:4599
|
Operating Income
¥142.4m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Takara Bio Inc's Operating Income?
Operating Income
1.5B
JPY
Based on the financial report for Dec 31, 2023, Takara Bio Inc's Operating Income amounts to 1.5B JPY.
What is Takara Bio Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-2%
Over the last year, the Operating Income growth was -95%. The average annual Operating Income growth rates for Takara Bio Inc have been -49% over the past three years , -21% over the past five years , and -2% over the past ten years .